Amin Waly

I help pharma and biotech teams solve complex commercialization challenges in rare disease and specialty care, especially where global strategy needs to translate into real-world launch and market impact.

I bring 12+ years of global and regional experience across hematology, immunology, oncology, and plasma-derived therapies, having led global brand strategy, launch excellence, portfolio prioritization, and market expansion across EUCAN, ICMEA, and international markets. I work effectively with senior leadership, cross-functional teams, and affiliates to simplify complexity and drive clear, actionable decisions.

What sets me apart is my ability to bridge strategy and execution. I don’t stop at frameworks; I design practical solutions that teams can implement, whether that’s defining positioning and go-to-market strategy, optimizing launch sequencing, improving portfolio and indication decisions, or strengthening regional and local execution.

Typical projects and deliverables include global and regional launch strategy, brand positioning and messaging, portfolio and indication prioritization models, market expansion and distributor strategy, omnichannel and commercial transformation initiatives, and executive-ready recommendations and playbooks.